Mitchell Sinkler & Starr Portfolio Holdings

Mitchell Sinkler & Starr

  • $353 Million
  • Q1 2025

Mitchell Sinkler & Starr has filed its 13F form on May 07, 2025 for Q1 2025 where it was disclosed a total value porftolio of $353 Million distributed in 152 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apple Inc. with a value of $21.9M, Microsoft Corp with a value of $21.8M, Abbott Laboratories with a value of $12.3M, Jpmorgan Chase & CO with a value of $11.7M, and Johnson & Johnson with a value of $10.7M.

Examining the 13F form we can see an decrease of $17.5M in the current position value, from $370M to 353M.

Below you can find more details about Mitchell Sinkler & Starr portfolio as well as his latest detailed transactions.

Portfolio value $353 Million
Technology: $76.3 Million
Healthcare: $44.5 Million
ETFs: $44.1 Million
Financial Services: $39.2 Million
Industrials: $36.4 Million
Consumer Defensive: $31 Million
Communication Services: $25.2 Million
Consumer Cyclical: $20.9 Million
Other: $35.3 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$122B
$507,000 0.14% of portfolio
1,135
Q1 2025 Added 2.25%
$19.3B
$477,000 0.14% of portfolio
3,974
Q1 2025 Added 25.64%
$0
$476,000 0.13% of portfolio
1,500
Q4 2023 New
$11B
$468,000 0.13% of portfolio
3,960
Q1 2025 Added 45.32%
$69.1B
$474,000 0.13% of portfolio
11,239
Q1 2025 Reduced 0.98%
$172B
$455,000 0.13% of portfolio
897
Q3 2024 Added 12.55%
$19B
$407,000 0.12% of portfolio
940
Q1 2025 Added 8.67%
$39.2B
$440,000 0.12% of portfolio
5,865
Q1 2025 Reduced 40.33%
$8.65B
$377,000 0.11% of portfolio
5,635
Q1 2025 Added 18.26%
$40.5B
$378,000 0.11% of portfolio
3,386
Q1 2025 Added 6.28%
$0
$399,000 0.11% of portfolio
2,306
Q1 2025 Reduced 14.78%
$14.8B
$379,000 0.11% of portfolio
4,550
Q1 2025 Reduced 11.65%
$0
$385,000 0.11% of portfolio
686
Q1 2024 Reduced 57.34%
$9.36B
$382,000 0.11% of portfolio
3,018
Q1 2025 Reduced 4.13%
$10.1B
$341,000 0.1% of portfolio
2,108
Q1 2025 Reduced 7.87%
$62.6B
$370,000 0.1% of portfolio
1,400
Q1 2025 New
$182B
$368,000 0.1% of portfolio
961
Q1 2025 Reduced 2.73%
$16.3B
$356,000 0.1% of portfolio
850
Q1 2025 Reduced 13.71%
$74.5B
$313,000 0.09% of portfolio
1,905
Q1 2025 Reduced 31.87%
$10.7B
$309,000 0.09% of portfolio
2,720
Q3 2024 Added 21.16%
$156B
$312,000 0.09% of portfolio
5,240
Q1 2025 Reduced 11.78%
$219B
$305,000 0.09% of portfolio
978
Q4 2024 Added 2.62%
$165B
$309,000 0.09% of portfolio
622
Q4 2024 Added 5.96%
$11.9B
$332,000 0.09% of portfolio
8,470
Q1 2025 Reduced 5.57%
$7.21B
$328,000 0.09% of portfolio
1,335
Q1 2025 Added 10.33%
$0
$321,000 0.09% of portfolio
5,294
Q1 2025 Added 64.67%
$0
$299,000 0.08% of portfolio
2,625
Q1 2025 Added 31.91%
$0
$292,000 0.08% of portfolio
1,700
Q4 2023 New
$53.1B
$269,000 0.08% of portfolio
1,750
Q2 2024 New
$0
$274,000 0.08% of portfolio
2,850
Q4 2024 Reduced 5.0%
$0
$267,000 0.08% of portfolio
740
Q1 2025 Added 8.82%
$44.5B
$278,000 0.08% of portfolio
6,090
Q1 2025 Reduced 6.31%
$0
$286,000 0.08% of portfolio
2,345
Q4 2023 New
$59.2B
$241,000 0.07% of portfolio
2,305
Q1 2025 Reduced 39.66%
$0
$255,000 0.07% of portfolio
4,385
Q3 2024 Added 74.7%
$25.8B
$237,000 0.07% of portfolio
1,386
Q1 2025 Reduced 1.77%
$272B
$205,000 0.06% of portfolio
765
Q3 2024 New
$98.4B
$204,000 0.06% of portfolio
1,830
Q1 2025 New
$31.6B
$227,000 0.06% of portfolio
3,809
Q1 2025 Reduced 6.16%
$47.7B
$202,000 0.06% of portfolio
2,800
Q4 2024 New
$0
$208,000 0.06% of portfolio
9,290
Q1 2025 Reduced 16.23%
$0
$206,000 0.06% of portfolio
1,000
Q1 2025 Added 11.11%
$79.5B
$192,000 0.05% of portfolio
1,537
Q1 2025 Reduced 13.02%
$0
$60,000 0.02% of portfolio
13,750
Q4 2023 New
$0
$0 0.0% of portfolio
11,600
Q1 2025 Added 6.67%
Solventum Corp
-
$0 0.0% of portfolio
-
Q1 2025 Added 2.07%
Ge Healthcare Technologies I
-
$0 0.0% of portfolio
-
Q1 2025 Added 2.38%
Ge Vernova Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 17.43%
Kenvue Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 3.53%

Summary

  • Portfolio
  • No. of Stocks 152
  • Current Value $353 Million
  • Prior Value $370 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 07, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 59 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 65 stocks
Track This Portfolio

Track Mitchell Sinkler & Starr Portfolio

Follow Mitchell Sinkler & Starr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email